Europace

Article	Citations
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation	581
Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)	185
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of gen	176
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy	171
EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rh	141
Deep learning and the electrocardiogram: review of the current state-of-the-art	141
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide	131
Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation	126
Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)	115
Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation	107
EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS	103
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association	103
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference	100
The V6-V1 interpeak interval: a novel criterion for the diagnosis of left bundle branch capture	99
EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry	95
Cardiac resynchronization therapy via left bundle branch pacing vs. optimized biventricular pacing with adaptive algorithm in heart failure with left bundle branch block: a prospective, multi-centre,	82
‘Hot phase’ clinical presentation in arrhythmogenic cardiomyopathy	80
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial	78
High-power short duration vs. conventional radiofrequency ablation of atrial fibrillation: a systematic review and meta-analysis	67
Corrigendum to: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation	63
The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: centre and patient experiences	56
The feasibility and safety of left bundle branch pacing vs. right ventricular pacing after mid-long-term follow-up: a single-centre experience	55
Accuracy of left atrial fibrosis detection with cardiac magnetic resonance: correlation of late gadolinium enhancement with endocardial voltage and conduction velocity	54
EHRA clinical consensus statement on conduction system pacing implantation: executive summary. Endorsed by the Asia-Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS) and Latin	53
Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation	52

Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019	52
Conduction system pacing in everyday clinical practice: EHRA physician survey	51
Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals	51
Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper	50
Randomized comparison of oesophageal protection with a temperature control device: results of the IMPACT study	50
Epidemiology of cardiac implantable electronic device infections: incidence and risk factors	50
Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial	47
Long-term performance and risk factors analysis after permanent His-bundle pacing and atrioventricular node ablation in patients with atrial fibrillation and heart failure	47
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis	47
Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF study	46
Local catheter impedance drop during pulmonary vein isolation predicts acute conduction block in patients with paroxysmal atrial fibrillation: initial results of the LOCALIZE clinical trial	45
EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm S	43
Radiofrequency ablation: technological trends, challenges, and opportunities	43
Clinical characteristics and risk stratification of desmoplakin cardiomyopathy	43
Association between sodium–glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials	43
Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology Cardiovascular Round Table	42
Safety of very high-power short-duration radiofrequency ablation for pulmonary vein isolation: a two-centre report with emphasis on silent oesophageal injury	41
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international Registry	41
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference	41
Risk stratification of patients undergoing transvenous lead extraction with the ELECTRa Registry Outcome Score (EROS): an ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry analysis	40
Pulmonary vein isolation alone vs. more extensive ablation with defragmentation and linear ablation of persistent atrial fibrillation: the EARNEST-PVI trial	40
Findings from repeat ablation using high-density mapping after pulmonary vein isolation with pulsed field ablation	39
Targeting non-pulmonary vein triggers in persistent atrial fibrillation: results from a prospective, multicentre, observational registry	39
Very high-power short-duration ablation for pulmonary vein isolation utilizing a very-close protocol—the FAST AND FURIOUS PVI study	39
Novel left ventricular cardiac synchronization: left ventricular septal pacing or left bundle branch pacing?	38
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study	37
Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade	37
How does the level of pulmonary venous isolation compare between pulsed field ablation and thermal energy ablation (radiofrequency, cryo, or laser)?	37
Personalized paroxysmal atrial fibrillation ablation by tailoring ablation index to the left atrial wall thickness: the ‘Ablate by-LAW’ single-centre study—a pilot study	36
Severe acute kidney injury related to haemolysis after pulsed field ablation for atrial fibrillation	36
Conduction system pacing, a European survey: insights from clinical practice	36
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal	36
Incidence, epidemiology, diagnosis and prognosis of atrio-oesophageal fistula following percutaneous catheter ablation: a French nationwide survey	35
Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study	35
Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS/LAHRS/APHRS	35
The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey	35
The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both diseases	34
Cardiac ablation with pulsed electric fields: principles and biophysics	33
Long-term clinical impact of permanent pacemaker implantation in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis	33
Critical appraisal of technologies to assess electrical activity during atrial fibrillation: a position paper from the European Heart Rhythm Association and European Society of Cardiology Working Grou	33
Risk factor management and atrial fibrillation	33
Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker	33
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)	32
Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope	32
Personalized ablation vs. conventional ablation strategies to terminate atrial fibrillation and prevent recurrence	32
Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial	31
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care	31
Reconstruction of three-dimensional biventricular activation based on the 12-lead electrocardiogram via patient-specific modelling	31
European experience with a first totally leadless cardiac resynchronization therapy pacemaker system	31
Cardiac operations and interventions during the COVID-19 pandemic: a nationwide perspective	31

Does isolation of the left atrial posterior wall using cryoballoon ablation improve clinical outcomes in patients with persistent atrial fibrillation? A prospective randomized controlled trial	31
His bundle pacing capture threshold stability during long-term follow-up and correlation with lead slack	30
Current perspectives on wearable rhythm recordings for clinical decision-making: the wEHRAbles 2 survey	30
Optimizing cryoballoon pulmonary vein isolation: lessons from >1000 procedures— the Frankfurt approach	30
Likelihood of injury due to vasovagal syncope: a systematic review and meta-analysis	30
ESC working group on cardiac cellular electrophysiology position paper: relevance, opportunities, and limitations of experimental models for cardiac electrophysiology research	30
Outcomes after cryoballoon ablation of paroxysmal atrial fibrillation with the PolarX or the Arctic Front Advance Pro: a prospective multicentre experience	30
Comparison of methods for delivering cardiac resynchronization therapy: an acute electrical and haemodynamic within-patient comparison of left bundle branch area, His bundle, and biventricular pacing	30
Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future	29
Efficacy and safety of left atrial appendage electrical isolation during catheter ablation of atrial fibrillation: an updated meta-analysis	28
Bipolar ablation of therapy-refractory ventricular arrhythmias: application of a dedicated approach	28
The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review	28
Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects	28
Brugada syndrome and syncope: a practical approach for diagnosis and treatment	28
Pulsed field ablation using focal contact force-sensing catheters for treatment of atrial fibrillation: acute and 90-day invasive remapping results	27
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey	27
Progressive involvement of cardiac conduction system in paediatric patients with Kearns–Sayre syndrome: how to predict occurrence of complete heart block and sudden cardiac death?	27
2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic	27
Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials	27
Progress in atrial fibrillation ablation during 25 years of Europace journal	27
Relationship between procedural volume and complication rates for catheter ablation of atrial fibrillation: a systematic review and meta-analysis	26
First experience with pulsed field ablation as routine treatment for paroxysmal atrial fibrillation	26
The evolution of cardiac resynchronization therapy and an introduction to conduction system pacing: a conceptual review	26
STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and re	26
Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study	26
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study	26
Low-voltage area substrate modification for atrial fibrillation ablation: a systematic review and meta-analysis of clinical trials	25
Pediatric catheter ablation at the beginning of the 21st century: results from the European Multicenter Pediatric Catheter Ablation Registry ‘EUROPA’	25
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe	25
2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment—Authors’ reply	25
Obstructive sleep apnoea testing and management in atrial fibrillation patients: a joint survey by the European Heart Rhythm Association (EHRA) and the Association of Cardiovascular Nurses and Allied	25
Anatomical-based percutaneous left stellate ganglion block in patients with drug-refractory electrical storm and structural heart disease: a single-centre case series	25
Using a smartwatch electrocardiogram to detect abnormalities associated with sudden cardiac arrest in young adults	25
Age-related tilt test responses in patients with suspected reflex syncope	24
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries	24
Novel cryoballoon ablation system for pulmonary vein isolation: multicenter assessment of efficacy and safety—ANTARCTICA study	24
Loss-of-function mutations in cardiac ryanodine receptor channel cause various types of arrhythmias including long QT syndrome	24
Long-term observation of catheter ablation vs. pharmacotherapy in the management of persistent and long-standing persistent atrial fibrillation (CAPA study)	24
Feasibility and efficacy of left bundle branch area pacing in patients indicated for cardiac resynchronization therapy	23
The digital journey: 25 years of digital development in electrophysiology from an Europace perspective	23
Infanticide vs. inherited cardiac arrhythmias	23
Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide	23
Causes, circumstances, and potential preventability of cardiac arrest in the young: insights from a state-wide clinical and forensic registry	23
Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score	23
Reduction in new cardiac electronic device implantations in Catalonia during COVID-19	23
Comparison of various late gadolinium enhancement magnetic resonance imaging methods with high-definition voltage and activation mapping for detection of atrial cardiomyopathy	23
An artificial intelligence–based model for prediction of atrial fibrillation from single-lead sinus rhythm electrocardiograms facilitating screening	22
Magnetic resonance assessment of left atrial scar formation following a novel very high-power short-duration workflow for atrial fibrillation ablation	22
AFA-Recur: an ESC EORP AFA-LT registry machine-learning web calculator predicting atrial fibrillation recurrence after ablation	22
The GermAn Laser Lead Extraction RegistrY: GALLERY	22
Focal Impulse and Rotor Modulation Ablation vs. Pulmonary Vein isolation for the treatment of paroxysmal Atrial Fibrillation: results from the FIRMAP AF study	22
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study	22
Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death	22
Lead performance and clinical outcomes of patients with permanent His-Purkinje system pacing: a single-centre experience	22
Identification of local atrial conduction heterogeneities using high-density conduction velocity estimation	22
Safety, effectiveness, and quality of life following pulmonary vein isolation with a multi-electrode radiofrequency balloon catheter in paroxysmal atrial fibrillation: 1-year outcomes from SHINE	22
A VIRTUAL Sleep Apnoea management pathway For the work-up of Atrial fibrillation patients in a digital Remote Infrastructure: VIRTUAL-SAFARI	22
Evidence-based insights on ideal blanking period duration following atrial fibrillation catheter ablation	21
A meta-analysis of clinical risk factors for stroke in anticoagulant-naïve patients with atrial fibrillation	21
Early atrial fibrillation detection and the transition to comprehensive management	21
Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison	21
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death	21
Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis	21
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA	21
Improved prediction of sudden cardiac death in patients with heart failure through digital processing of electrocardiography	21
The influence of atrial high-rate episodes on stroke and cardiovascular death: an update	21
Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation	21
Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial	21
The blanking period after atrial fibrillation ablation: an European Heart Rhythm Association survey on contemporary definition and management	21
Cryoballoon vs. radiofrequency catheter ablation: insights from NOrwegian randomized study of PERSistent Atrial Fibrillation (NO-PERSAF study)	21
Catheter ablation vs. antiarrhythmic drugs as ‘first-line’ initial therapy for atrial fibrillation: a pooled analysis of randomized data	20
Contemporary management of ventricular electrical storm in Europe: results of a European Heart Rhythm Association Survey	20
EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices	20
Smartphone electrocardiogram for detecting atrial fibrillation after a cerebral ischaemic event: a multicentre randomized controlled trial	20
Electrical markers and arrhythmic risk associated with myocardial fibrosis in mitral valve prolapse	20
Effect of remote monitoring on clinical outcomes in European heart failure patients with an implantable cardioverter-defibrillator: secondary results of the REMOTE-CIED randomized trial	20
Ventricular arrhythmias in arrhythmic mitral valve syndrome—a prospective continuous long-term cardiac monitoring study	20
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm	20
Machine learning in sudden cardiac death risk prediction: a systematic review	20
Acute safety, efficacy, and advantages of a novel cryoballoon ablation system for pulmonary vein isolation in patients with paroxysmal atrial fibrillation: initial clinical experience	20

Increased beat-to-beat variability of cerebral microcirculatory perfusion during atrial fibrillation: a near-infrared spectroscopy study	20
Diagnostic yield and financial implications of a nationwide electrocardiographic screening programme to detect cardiac disease in the young	20
Atrial fibrillation burden during the coronavirus disease 2019 pandemic	20
High-degree atrioventricular block in COVID-19 hospitalized patients	20
Accuracy of electroanatomical mapping-guided cardiac radiotherapy for ventricular tachycardia: pitfalls and solutions	20
Carbon footprint of atrial fibrillation catheter ablation	20
Miniseries 1—Part III: ‘Behind the scenes’ in the triangle of Koch	19
Twitter for professional use in electrophysiology: practical guide for #EPeeps	19
A randomized study of yoga therapy for the prevention of recurrent reflex vasovagal syncope	19
Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA	19
The SIDECAR project: S-IcD registry in European paediatriC and young Adult patients with congenital heaRt defects	19
Baseline left atrial low-voltage area predicts recurrence after pulmonary vein isolation: WAVE-MAP AF results	19
Atrial fibrillation progression and the importance of early treatment for improving clinical outcomes	19
Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort Study	19
Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1	19
Diagnostic yield and accuracy in a tertiary referral syncope unit validating the ESC guideline on syncope: a prospective cohort study	19
Adopting permanent His bundle pacing: learning curves and medium-term outcomes	19
Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis	19
The use of social media for professional purposes by healthcare professionals: the #intEHRAct survey	19
Risk stratification of sudden cardiac death: a review	19
Procedural efficiencies, lesion metrics, and 12-month clinical outcomes for Ablation Index-guided 50 W ablation for atrial fibrillation	18
Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey	18
Human biventricular electromechanical simulations on the progression of electrocardiographic and mechanical abnormalities in post-myocardial infarction	18
European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European H	18
Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction	18
European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death	18
Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium	18
Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis	18
Sleep apnoea has a dose-dependent effect on atrial remodelling in paroxysmal but not persistent atrial fibrillation: a high-density mapping study	18
Scar conducting channel characterization to predict arrhythmogenicity during ventricular tachycardia ablation	18
Acute oesophageal safety of high-power short duration with 50 W for atrial fibrillation ablation	18
Autoimmune diseases and new-onset atrial fibrillation: a UK Biobank study	18
New-onset atrial fibrillation following left bundle branch area pacing vs. right ventricular pacing: a two-centre prospective cohort study	18
Safety and efficacy of intracardiac echocardiography–guided zero-fluoroscopic cryoballoon ablation for atrial fibrillation: a prospective randomized controlled trial	18
The challenge of managing multimorbid atrial fibrillation: a pan-European European Heart Rhythm Association (EHRA) member survey of current management practices and clinical priorities	18
Pulmonary vein isolation with the radiofrequency balloon catheter: a single centre prospective study	18
From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies	18
Validation of a multipolar pulsed-field ablation catheter for endpoint assessment in pulmonary vein isolation procedures	18
Characteristics and clinical outcomes in atrial fibrillation patients classified using cluster analysis: the Fushimi AF Registry	18
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference	18
Life-threatening arrhythmias with autosomal recessive TECRL variants	17
Rate control drugs differ in the prevention of progression of atrial fibrillation	17
Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortality	17
Single shot electroporation of premature ventricular contractions from the right ventricular outflow tract	17
Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19	17
Determinants of acute irreversible electroporation lesion characteristics after pulsed field ablation: the role of voltage, contact, and adipose interference	17
Cardiovascular magnetic resonance determinants of ventricular arrhythmic events after myocardial infarction	17
The evolving state of cardiac resynchronization therapy and conduction system pacing: 25 years of research at EP Europace journal	17
Prevalence of asystole during tilt test-induced vasovagal syncope may depend on test methodology	17
Differences in atrial substrate localization using late gadolinium enhancement-magnetic resonance imaging, electrogram voltage, and conduction velocity: a cohort study using a consistent anatomical re	17
Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-	17
Radiofrequency ablation to achieve durable pulmonary vein isolation	17
Sinus rhythm voltage fingerprinting in patients with mitral valve disease using a high-density epicardial mapping approach	17
Epicardial adipose tissue modulates arrhythmogenesis in right ventricle outflow tract cardiomyocytes	17
Impact of oral anticoagulation on the association between frailty and clinical outcomes in people with atrial fibrillation: nationwide primary care records on treatment analysis	17
Endomysial fibrosis, rather than overall connective tissue content, is the main determinant of conduction disturbances in human atrial fibrillation	17
Long-term outcomes in a randomized controlled trial of multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy	17
Budget impact analysis of a machine learning algorithm to predict high risk of atrial fibrillation among primary care patients	17
Personalized pulmonary vein antrum isolation guided by left atrial wall thickness for persistent atrial fibrillation	16
Enrichment of loss-of-function and copy number variants in ventricular cardiomyopathy genes in ‘lone’ atrial fibrillation	16
Life-threatening ventricular arrhythmia prediction in patients with dilated cardiomyopathy using explainable electrocardiogram-based deep neural networks	16
Catheter ablation of intramural outflow tract premature ventricular complexes: a multicentre study	16
Efficacy and safety of same-day discharge after atrial fibrillation ablation compared with post-procedural overnight stay: a systematic review and meta-analysis	16
Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis	16
Utilization and perception of same-day discharge in electrophysiological procedures and device implantations: an EHRA survey	16
Timing of cardiac resynchronization therapy implantation	16
Upgrading right ventricular pacemakers to biventricular pacing or conduction system pacing: a systematic review and meta-analysis	16
The evidence for the implantable loop recorder in patients with inherited arrhythmia syndromes: a review of the literature	16
Efficacy and safety of a novel cryoballoon ablation system: multicentre comparison of 1-year outcome	16
Role of pre-operative transthoracic echocardiography in predicting post-operative atrial fibrillation after cardiac surgery: a systematic review of the literature and meta-analysis	16
Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey	16
Effect of alcohol consumption on the risk of adverse events in atrial fibrillation: from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)	16
Prevalence and clinical significance of isolated low QRS voltages in young athletes	16
Association between left atrial epicardial fat, left atrial volume, and the severity of atrial fibrillation	16
Quantitative assessment of transmural fibrosis profile in the human atrium: evidence for a three-dimensional arrhythmic substrate by slice-to-slice histology	15
Effects of intensive blood pressure control on cardiovascular and cognitive outcomes in patients with atrial fibrillation: insights from the SPRINT trial	15
Left ventricular shape predicts arrhythmic risk in fibrotic dilated cardiomyopathy	15
Procedural outcome and follow-up of stylet-driven leads compared with lumenless leads for left bundle branch area pacing	15
Combination of current and new electrocardiographic-based criteria: a novel score for the discrimination of left bundle branch capture	15
Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review	15
Prediction of low-voltage areas using modified APPLE score	15
In vivopulsed-field ablation in healthy vs. chronically infarcted ventricular myocardium: biophysical and histologic characterization	15
Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices	15
Cardiac resynchronization therapy non-responder to responder conversion rate in the MORE-CRT MPP trial	15
Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis	15
Efficacy and safety of pulmonary vein isolation with pulsed field ablation vs. novel cryoballoon ablation system for atrial fibrillation	15
Leadless left ventricular endocardial pacing for CRT upgrades in previously failed and high-risk patients in comparison with coronary sinus CRT upgrades	15
Clinical and electrophysiological predictors of device-detected new-onset atrial fibrillation during 3 years after cardiac surgery	15
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death	15
360° Virtual reality to improve patient education and reduce anxiety towards atrial fibrillation ablation	15
The adjunctive effect for left pulmonary vein isolation of vein of Marshall ethanol infusion in persistent atrial fibrillation	15
Sports-related sudden cardiac arrest in young adults	15
Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey	15
Cardiac magnetic resonance to predict recurrences after ventricular tachycardia ablation: septal involvement, transmural channels, and left ventricular mass	15
Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET)	15